Primary Site >> Pancreatic Cancer

Gene >> FBXW7

Journal: Am J Pathol. 2003 Oct;163(4):1255-60.
Title: BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.
Author: Calhoun, Eric S|Jones, Jessa B|Ashfaq, Raheela|Adsay, Volkan|Baker, Suzanne J|Valentine, Virginia|Hempen, Paula M|Hilgers, Werner|Yeo, Charles J|Hruban, Ralph H|Kern, Scott E
PMID: 14507635
Journal: Cancer Res. 2007 Apr 15;67(8):3545-50.
Title: Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
Author: Balakrishnan, Asha|Bleeker, Fonnet E|Lamba, Simona|Rodolfo, Monica|Daniotti, Maria|Scarpa, Aldo|van Tilborg, Angela A|Leenstra, Sieger|Zanon, Carlo|Bardelli, Alberto
PMID: 17440062
Journal: Curr Drug Targets. 2013 Sep;14(10):1150-6.
Title: Genistein down-regulates miR-223 expression in pancreatic cancer cells.
Author: Ma, Jia|Cheng, Long|Liu, Hao|Zhang, Jing|Shi, Ying|Zeng, Fanpeng|Miele, Lucio|Sarkar, Fazlul H|Xia, Jun|Wang, Zhiwei
PMID: 23834147
Journal: Oncotarget. 2014 Jun 15;5(11):3444-54.
Title: Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.
Author: Gao, Jiankun|Azmi, Asfar S|Aboukameel, Amro|Kauffman, Michael|Shacham, Sharon|Abou-Samra, Abdul-Badi|Mohammad, Ramzi M
PMID: 24899509
Journal: Oncotarget. 2015 Mar 10;6(7):4553-61.
Title: Molecular landscape of pancreatic cancer: implications for current clinical trials.
Author: Heestand, Gregory M|Kurzrock, Razelle
PMID: 11051691
Journal: Oncotarget. 2015 Jan 30;6(3):1740-9.
Title: Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Author: Ma, Jia|Fang, Binbin|Zeng, Fanpeng|Ma, Cong|Pang, Haijie|Cheng, Long|Shi, Ying|Wang, Hui|Yin, Bin|Xia, Jun|Wang, Zhiwei
PMID: 25638153
Journal: Oncotarget. 2015 Mar 10;6(7):4553-61.
Title: Molecular landscape of pancreatic cancer: implications for current clinical trials.
Author: Heestand, Gregory M|Kurzrock, Razelle
PMID: 25714017
Journal: Cell Res. 2015 May;25(5):561-73.
Title: ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Author: Ji, Shunrong|Qin, Yi|Shi, Si|Liu, Xiangyuan|Hu, Hongli|Zhou, Hu|Gao, Jing|Zhang, Bo|Xu, Wenyan|Liu, Jiang|Liang, Dingkong|Liu, Liang|Liu, Chen|Long, Jiang|Zhou, Haijun|Chiao, Paul J|Xu, Jin|Ni, Quanxing|Gao, Daming|Yu, Xianjun
PMID: 25753158
Journal: Clin Cancer Res. 2016 Aug 1;22(15):3950-60.
Title: FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.
Author: Ji, Shunrong|Qin, Yi|Liang, Chen|Huang, Run|Shi, Si|Liu, Jiang|Jin, Kaizhou|Liang, Dingkong|Xu, Wenyan|Zhang, Bo|Liu, Liang|Liu, Chen|Xu, Jin|Ni, Quanxing|Chiao, Paul J|Li, Min|Yu, Xianjun
PMID: 26983463
Journal: Neoplasia. 2016 Nov;18(11):666-673.
Title: Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation.
Author: Zhang, Qiang|Zhang, Yaqing|Parsels, Joshua D|Lohse, Ines|Lawrence, Theodore S|Pasca di Magliano, Marina|Sun, Yi|Morgan, Meredith A
PMID: 27764699
Journal: Tumour Biol. 2016 Oct;37(10):13893-13902.
Title: Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting beta-catenin for degradation in pancreatic cancer.
Author: Jiang, Jian-Xin|Sun, Cheng-Yi|Tian, She|Yu, Chao|Chen, Mei-Yuan|Zhang, Hao
PMID: 27485116
Journal: J Gastrointest Oncol. 2016 Apr;7(2):E6-E12.
Title: Molecular profiling of a case of advanced pancreatic cancer identifies an active and tolerable combination of targeted therapy with backbone chemotherapy.
Author: Johnson, Benny|Vanderwalde, Ari|Javadi, Nader|Feldman, Rebecca|Reddy, Sandeep Bobby
PMID: 27034805
Journal: Oncotarget. 2017 Feb 28;8(9):14620-14635.
Title: Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture.
Author: Xu, Meng-Dan|Liu, Shu-Ling|Feng, Yi-Zhong|Liu, Qiang|Shen, Meng|Zhi, Qiaoming|Liu, Zeyi|Gu, Dong-Mei|Yu, Jie|Shou, Liu-Mei|Gong, Fei-Ran|Zhu, Qi|Duan, Weiming|Chen, Kai|Zhang, Junning|Wu, Meng-Yao|Tao, Min|Li, Wei
PMID: 28099906
Journal: J Biol Chem. 2017 Apr 14;292(15):6269-6280.
Title: CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
Author: Jin, Xin|Yang, Chong|Fan, Ping|Xiao, Jun|Zhang, Wanli|Zhan, Sudong|Liu, Tao|Wang, Dejie|Wu, Heshui
PMID: 28242758
Journal: J Gastrointest Oncol. 2017 Feb;8(1):164-172.
Title: Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.
Author: Borazanci, Erkut|Millis, Sherri Z|Kimbrough, Jeffery|Doll, Nancy|Von Hoff, Daniel|Ramanathan, Ramesh K
PMID: 28280620
Journal: Oncol Rep. 2017 Oct;38(4):2069-2077.
Title: FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.
Author: Hu, Qiangsheng|Qin, Yi|Zhang, Bo|Liang, Chen|Ji, Shunrong|Shi, Si|Xu, Wenyan|Xiang, Jinfeng|Liang, Dingkong|Ni, Quanxing|Yu, Xianjun|Xu, Jin
PMID: 28765935
Journal: Oncotarget. 2017 Nov 6;8(68):112636-112646.
Title: Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.
Author: Ishii, Norihiro|Araki, Kenichiro|Yokobori, Takehiko|Gantumur, Dorgormaa|Yamanaka, Takahiro|Altan, Bolag|Tsukagoshi, Mariko|Igarashi, Takamichi|Watanabe, Akira|Kubo, Norio|Hosouchi, Yasuo|Kuwano, Hiroyuki|Shirabe, Ken
PMID: 29348852